Project Details
Description
A Multicenter, Single-Arm, Open-Label, Extension, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab in Patients with Multiple Sclerosis
| Status | Active |
|---|---|
| Effective start/end date | 9/9/22 → 2/28/28 |
Funding
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.